Company intelligence / Profile preview

KorvaLabs

San Dimas, California, United States

Ownership: Private
Development stage: Other

Overview

KorvaLabs is a CLIA-certified mass spectrometry laboratory specializing in clinical diagnostics, sports anti-doping, and research services. It was acquired by Curative in May 2020 and contributed significantly to scaling up COVID-19 testing.

Therapeutic areas: OtherPsychiatry
Modalities: Mass spectrometry analytes
Industry: Protein Biomarker Diagnostics

Partnerships

Curative Inc.

Beyond the preview

Go deeper on KorvaLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KorvaLabs.

Explore the full profile